Memphasys LtdASX: MEM

Leading Brazilian Andrology Clinic to test Felix System

· Issued by Memphasys Ltd

Filed with ASX · · 3 pages · English

Summary by 6ix AI

Memphasys Ltd has announced the commencement of clinical utility testing of the Felix™ System in Brazil, collaborating with Laboratorio Androscience, a leading Brazilian andrology clinic. The testing will benchmark the Felix™ System against existing sperm preparation processes and is expected to run over three months. Memphasys aims to enter the Brazilian IVF market, which is projected to experience significant growth, with potential expansions into Latin America. The company is also engaging with investors interested in supporting its market entry through a licensing arrangement.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Memphasys Ltd on 6ix

Story so far

Earlier from Memphasys

Later from Memphasys

All Memphasys news releases